Quarterly report pursuant to sections 13 or 15(d)

General

v2.3.0.11
General
6 Months Ended
Jun. 30, 2011
Notes to Financial Statements  
General

Amarantus BioSciences, Inc. (the “Company”) was incorporated on January 14, 2008 in the state of Delaware. The Company is a development stage biopharmaceutical drug development company dedicated to sourcing high-potential therapeutic platform technologies and aligning their development with complementary clinical-stage compounds to reduce overall enterprise risk. Through June 30, 2011, the Company has been primarily engaged in biotechnology research and development and raising capital.